Simrén Magnus, Ringström Gisela, Björnsson Einar S, Abrahamsson Hasse
Department of Internal Medicine, Sahlgrenska University Hospital, Göteborg, Sweden.
Psychosom Med. 2004 Mar-Apr;66(2):233-8. doi: 10.1097/01.psy.0000116964.76529.6e.
Postprandial symptoms in irritable bowel syndrome are common and relate to an exaggerated motor and sensory component of the gastrocolonic response. We investigated whether this response can be affected by hypnotherapy.
We included 28 patients with irritable bowel syndrome refractory to other treatments. They were randomized to receive gut-directed hypnotherapy 1 hour per week for 12 weeks (N = 14) or were provided with supportive therapy (control group; N = 14). Before randomization and after 3 months, all patients underwent a colonic distension trial before and after a 1-hour duodenal lipid infusion. Colonic sensory thresholds and tonic and phasic motor activity were assessed.
Before randomization, reduced thresholds after vs. before lipid infusion were seen in both groups for all studied sensations. At 3 months, the colonic sensitivity before duodenal lipids did not differ between groups. Controls reduced their thresholds after duodenal lipids for gas (22 +/- 1.7 mm Hg vs. 16 +/- 1.6 mm Hg, p <.01), discomfort (29 +/- 2.9 mm Hg vs. 22 +/- 2.6 mm Hg, p <.01), and pain (33 +/- 2.7 mm Hg vs. 26 +/- 3.3 mm Hg, p <.01), whereas the hypnotherapy group reduced their thresholds after lipids only for pain (35 +/- 4.0 mm Hg vs. 29 +/- 4.7 mm Hg, p <.01). The colonic balloon volumes and tone response at randomization were similar in both groups. At 3 months, baseline balloon volumes were lower in the hypnotherapy group than in controls (83 +/- 14 ml vs. 141 +/- 15 ml, p <.01). In the control group, reduced balloon volumes during lipid infusion were seen (141 +/- 15 ml vs. 111 +/- 19 ml, p <.05), but not after hypnotherapy (83 +/- 14 ml vs. 80 +/- 16 ml, p >.20).
Hypnotherapy reduces the sensory and motor component of the gastrocolonic response in patients with irritable bowel syndrome. These effects may be involved in the clinical efficacy of hypnotherapy in IBS.
肠易激综合征的餐后症状很常见,且与胃结肠反应中过度的运动和感觉成分有关。我们研究了催眠疗法是否会影响这种反应。
我们纳入了28例对其他治疗无效的肠易激综合征患者。他们被随机分为两组,一组每周接受1小时的肠道定向催眠疗法,共12周(N = 14),另一组接受支持性治疗(对照组;N = 14)。在随机分组前和3个月后,所有患者在1小时十二指肠脂质输注前后均进行结肠扩张试验。评估结肠感觉阈值以及紧张性和阶段性运动活动。
随机分组前,两组在所有研究感觉方面,脂质输注后与输注前相比阈值均降低。3个月时,十二指肠脂质输注前两组的结肠敏感性无差异。对照组在十二指肠脂质输注后气体阈值降低(22±1.7 mmHg对16±1.6 mmHg,p<.01)、不适阈值降低(29±2.9 mmHg对22±2.6 mmHg,p<.01)、疼痛阈值降低(33±2.7 mmHg对26±3.3 mmHg,p<.01),而催眠疗法组仅在脂质输注后疼痛阈值降低(35±4.0 mmHg对29±4.7 mmHg,p<.01)。两组随机分组时结肠气囊体积和张力反应相似。3个月时,催眠疗法组的基线气囊体积低于对照组(83±14 ml对141±15 ml,p<.01)。在对照组中,脂质输注期间气囊体积减小(141±15 ml对111±19 ml,p<.05),但催眠疗法后未减小(83±14 ml对80±16 ml,p>.20)。
催眠疗法可降低肠易激综合征患者胃结肠反应的感觉和运动成分。这些作用可能与催眠疗法对肠易激综合征的临床疗效有关。